The Gel Extraction industry trends over the past 18 months reveal a pivot toward automation-compatible, low-melt agarose chemistries as NGS labs race to cut turnaround times. In March 2024, Thermo Fisher quietly acquired Swedish start-up GelTech AB for its enzyme-free, 45-second recovery platform, folding the IP into the GeneJET line slated for Q4 launch. Meanwhile, Zymo Research partnered with Hamilton to embed a new silica-membrane tip in liquid handlers, eliminating the need for centrifugation and reducing plastic waste 38%. Regulatory momentum arrived when the FDA updated its LDT guidance in January 2024, classifying gel-extracted nucleic acids as โcritical components,โ forcing kit makers to add in-process stability data; smaller suppliers are scrambling to comply by 2025. On the funding front, AmpureX Biosciences closed a $22 M Series B in September 2023 to scale its magnetic-bead-free, room-temperature storage reagents, targeting field-deployable diagnostics in LATAM and APAC. Customers now rank โcold-chain independenceโ and ISO 14040 footprint scores as top procurement criteria, pushing vendors to publish third-party verified EPDs ahead of the 2026 procurement cycle.